Drug Index



Mechanism :

Granisetron is a selective 5-hydroxytryptamine 3 (5-HT3) receptor antagonist with little or no affinity for other serotonin receptors, including 5-HT1; 5-HT1A; 5-HT1B/C; 5-HT2; for alpha1-, alpha2-, or beta-adrenoreceptors; for dopamine-D2; or for histamine-H1; benzodiazepine; picrotoxin or opioid receptors.

Indication :

• Nausea and vomiting

Contraindications :

Contraindicated in patients with known hypersensitivity to the drug or any of its components.

Dosing :

Under 2 years: Safety and efficacy not established.

2-16 years: 0.01 mg/kg intravenous infusion over 5 minutes or half an hour before chemotherapy.

Adverse Effect :

Headache, diarrhea, asthenia, constipation, drowsiness, sedation, somnolence, abdominal pain and dyspepsia.

Interaction :

Phenytoin, Carbamazepine, and Rifampicin: The clearance of granisetron was significantly increased and ondansetron blood concentrations were decreased.

03/14/2020 09:11:37 Granisetron
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0